Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 19389648)

Published in Heart Rhythm on February 14, 2009

Authors

Christopher R Ellis1, Jeffrey N Rottman

Author Affiliations

1: University of Michigan, Cardiovascular Center, Ann Arbor, Michigan 48109, USA. chrellis@med.umich.edu

Articles by these authors

Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes (2007) 2.17

High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads. Heart Rhythm (2012) 1.88

Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet (2005) 1.61

Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38

Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest (2005) 1.34

Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ Res (2003) 1.33

Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol (2005) 1.20

Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am J Physiol Heart Circ Physiol (2005) 1.14

Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. J Physiol (2007) 1.10

Long chain fatty acid uptake in vivo: comparison of [125I]-BMIPP and [3H]-bromopalmitate. Lipids (2008) 0.94

Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93

Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Diabetes (2007) 0.93

Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. J Physiol (2005) 0.93

Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes (2005) 0.90

Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise. Am J Physiol Endocrinol Metab (2004) 0.87

Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol (2013) 0.83

Conductor extrusion in a persistent left superior vena cava. Europace (2011) 0.83

Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience. J Cardiovasc Electrophysiol (2013) 0.82

Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease. Am J Cardiol (2003) 0.81

Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. Biochim Biophys Acta (2008) 0.81

Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism. Am J Physiol Endocrinol Metab (2011) 0.81

AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Am J Physiol Endocrinol Metab (2004) 0.81

Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy. Dis Model Mech (2012) 0.79

Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death. J Am Soc Hypertens (2010) 0.78

Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart. Am J Physiol Cell Physiol (2013) 0.76

Familial evaluation for diagnosis of arrhythmogenic right ventricular dysplasia. Cardiology (2011) 0.75

Migration and infection of a pace-sense lead from an abdominal defibrillator system. Pacing Clin Electrophysiol (2002) 0.75

Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. J Cardiovasc Electrophysiol (2004) 0.75

Complete superior vena cava obstruction. J Am Coll Cardiol (2010) 0.75